Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder.

Suchting R, Yoon JH, Miguel GGS, Green CE, Weaver MF, Vincent JN, Fries GR, Schmitz JM, Lane SD.

Brain Res. 2019 Jul 30:146359. doi: 10.1016/j.brainres.2019.146359. [Epub ahead of print]

PMID:
31374218
2.

Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.

Yoon JH, Suchting R, McKay SA, San Miguel GG, Vujanovic AA, Stotts AL, Lane SD, Vincent JN, Weaver MF, Lin A, Schmitz JM.

Psychol Addict Behav. 2019 Jun 24. doi: 10.1037/adb0000475. [Epub ahead of print]

PMID:
31233323
3.

Assessing attentional bias and inhibitory control in cannabis use disorder using an eye-tracking paradigm with personalized stimuli.

Yoon JH, San Miguel GG, Vincent JN, Suchting R, Haliwa I, Weaver MF, Schmitz JM, Lane SD.

Exp Clin Psychopharmacol. 2019 Mar 25. doi: 10.1037/pha0000274. [Epub ahead of print]

PMID:
30907601
4.

Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.

Tong ST, Polak KM, Weaver MF, Villalobos GC, Smith WR, Svikis DS.

J Am Board Fam Med. 2019 Mar-Apr;32(2):272-278. doi: 10.3122/jabfm.2019.02.180172.

5.

A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.

Schmitz JM, Stotts AL, Vujanovic AA, Weaver MF, Yoon JH, Vincent J, Green CE.

Contemp Clin Trials. 2018 Feb;65:109-115. doi: 10.1016/j.cct.2017.12.015. Epub 2017 Dec 26.

6.

PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.

Schmitz JM, Green CE, Hasan KM, Vincent J, Suchting R, Weaver MF, Moeller FG, Narayana PA, Cunningham KA, Dineley KT, Lane SD.

Addiction. 2017 Oct;112(10):1861-1868. doi: 10.1111/add.13868. Epub 2017 Jul 3.

7.

Opioid Analgesics and Nicotine: More Than Blowing Smoke.

Yoon JH, Lane SD, Weaver MF.

J Pain Palliat Care Pharmacother. 2015 Sep;29(3):281-9. doi: 10.3109/15360288.2015.1063559. Epub 2015 Sep 16.

PMID:
26375198
8.

Prescription Sedative Misuse and Abuse.

Weaver MF.

Yale J Biol Med. 2015 Sep 3;88(3):247-56. eCollection 2015 Sep. Review.

9.

Balancing Beneficence and Autonomy.

Clark CD, Weaver MF.

Am J Bioeth. 2015;15(7):62-3. doi: 10.1080/15265161.2015.1042717. No abstract available.

PMID:
26147273
10.

Responsible opioid use.

Compton P, Weaver MF.

J Pain Palliat Care Pharmacother. 2015 Jun;29(2):166-8. doi: 10.3109/15360288.2015.1037522.

PMID:
26095489
11.

Designer drugs 2015: assessment and management.

Weaver MF, Hopper JA, Gunderson EW.

Addict Sci Clin Pract. 2015 Mar 25;10:8. doi: 10.1186/s13722-015-0024-7.

12.

Comparison of puff topography, toxicant exposure, and subjective effects in low- and high-frequency waterpipe users: a double-blind, placebo-control study.

Cobb CO, Blank MD, Morlett A, Shihadeh A, Jaroudi E, Karaoghlanian N, Kilgalen B, Austin J, Weaver MF, Eissenberg T.

Nicotine Tob Res. 2015 Jun;17(6):667-74. doi: 10.1093/ntr/ntu196. Epub 2014 Sep 25.

13.

Clinical laboratory assessment of the abuse liability of an electronic cigarette.

Vansickel AR, Weaver MF, Eissenberg T.

Addiction. 2012 Aug;107(8):1493-500. doi: 10.1111/j.1360-0443.2012.03791.x. Epub 2012 May 8.

14.

Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study.

Blank MD, Cobb CO, Kilgalen B, Austin J, Weaver MF, Shihadeh A, Eissenberg T.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):102-9. doi: 10.1016/j.drugalcdep.2010.11.026. Epub 2011 Feb 1.

15.

Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects.

Cobb CO, Shihadeh A, Weaver MF, Eissenberg T.

Nicotine Tob Res. 2011 Feb;13(2):78-87. doi: 10.1093/ntr/ntq212. Epub 2010 Dec 2.

16.

Alcohol-use disorders in the critically ill patient.

de Wit M, Jones DG, Sessler CN, Zilberberg MD, Weaver MF.

Chest. 2010 Oct;138(4):994-1003. doi: 10.1378/chest.09-1425. Review.

17.

A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1945-53. doi: 10.1158/1055-9965.EPI-10-0288. Epub 2010 Jul 20.

18.

The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention.

Cropsey KL, McClure LA, Jackson DO, Villalobos GC, Weaver MF, Stitzer ML.

Am J Public Health. 2010 Aug;100(8):1442-8. doi: 10.2105/AJPH.2009.172783. Epub 2010 Jun 17.

19.

Factors related to injection drug use among female prisoners.

Jackson DO, Cropsey KL, Weaver MF, Villalobos GC, Eldridge G, Stitzer ML.

Subst Use Misuse. 2010 Feb;45(3):368-83. doi: 10.3109/10826080903452454.

PMID:
20141453
20.

Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners.

Cropsey KL, Weaver MF, Eldridge GD, Villalobos GC, Best AM, Stitzer ML.

Nicotine Tob Res. 2009 Jun;11(6):690-7. doi: 10.1093/ntr/ntp051. Epub 2009 Apr 22.

21.

Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.

Cobb CO, Weaver MF, Eissenberg T.

Tob Control. 2010 Oct;19(5):367-73. doi: 10.1136/tc.2008.028993. Epub 2009 Apr 2.

22.

Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic.

Yanni LM, Weaver MF, Johnson BA, Morgan LA, Harrington SE, Ketchum JM.

J Opioid Manag. 2008 Jul-Aug;4(4):201-11.

PMID:
18837203
23.

The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.

Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T.

Exp Clin Psychopharmacol. 2008 Apr;16(2):99-112. doi: 10.1037/1064-1297.16.2.99.

PMID:
18489014
24.

Predictors of involvement in the juvenile justice system among psychiatric hospitalized adolescents.

Cropsey KL, Weaver MF, Dupre MA.

Addict Behav. 2008 Jul;33(7):942-8. doi: 10.1016/j.addbeh.2008.02.012. Epub 2008 Feb 23.

PMID:
18343040
25.

Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.

Blank MD, Sams C, Weaver MF, Eissenberg T.

Nicotine Tob Res. 2008 Mar;10(3):417-21. doi: 10.1080/14622200801901880.

26.

Addiction epidemiology in adolescents receiving inpatient psychiatric treatment.

Weaver MF, Dupre MA, Cropsey KL, Koch JR, Sood BA, Wiley JL, Balster RL.

Addict Behav. 2007 Dec;32(12):3107-13. Epub 2007 Jun 9.

27.

Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: a retrospective study.

de Wit M, Wan SY, Gill S, Jenvey WI, Best AM, Tomlinson J, Weaver MF.

BMC Anesthesiol. 2007 Mar 14;7:3.

28.

Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison.

Cropsey KL, Eldridge GD, Weaver MF, Villalobos GC, Stitzer ML.

Nicotine Tob Res. 2006 Oct;8(5):653-9.

PMID:
17008192
29.

Aberrant drug-taking behaviors and headache: patient versus physician report.

Weaver MF, Bond DS, Arnold BL, Waterhouse E, Towne A.

Am J Health Behav. 2006 Sep-Oct;30(5):475-82.

PMID:
16893310
30.

Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity.

Weaver MF, Hoffman HJ, Johnson RE, Mauck K.

J Addict Dis. 2006;25(2):17-24.

PMID:
16785215
31.

Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Evans SE, Blank M, Sams C, Weaver MF, Eissenberg T.

Exp Clin Psychopharmacol. 2006 May;14(2):121-35.

32.

HCV prevalence in methadone maintenance: self-report versus serum test.

Weaver MF, Cropsey KL, Fox SA.

Am J Health Behav. 2005 Sep-Oct;29(5):387-94.

PMID:
16201855
33.

Opioid treatment of chronic pain in patients with addiction.

Weaver MF, Schnoll SH.

J Pain Palliat Care Pharmacother. 2002;16(3):5-26. Review.

PMID:
14640352
34.

Addiction and pain.

Schnoll SH, Weaver MF.

Am J Addict. 2003;12(s2):S27-S35. Review.

PMID:
12857661
35.

A clinical laboratory model for direct assessment of medication-induced antihyperalgesia and subjective effects: initial validation study.

Eissenberg T, Riggins EC 3rd, Harkins SW, Weaver MF.

Exp Clin Psychopharmacol. 2000 Feb;8(1):47-60.

PMID:
10743904
36.

Role of the primary care physician in problems of substance abuse.

Weaver MF, Jarvis MA, Schnoll SH.

Arch Intern Med. 1999 May 10;159(9):913-24. Review.

PMID:
10326934
37.

Serotonin contributes to the spinal antinociceptive effects of morphine.

Crisp T, Stafinsky JL, Uram M, Perni VC, Weaver MF, Spanos LJ.

Pharmacol Biochem Behav. 1991 Jul;39(3):591-5.

PMID:
1686100

Supplemental Content

Loading ...
Support Center